2 assets in Premature Aging Syndrome

Therapeutic assets addressing Premature Aging Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Dasatinib Premature Aging Syndrome	Washington University School of Medicine	P2	CCC (53)
Flavone, 3,3',4',5,7-Pentahydroxy- Premature Aging Syndrome	Washington University School of Medicine	P2	CCC (53)